Disease	O
evolution	O
in	O
late	O
-	O
onset	O
and	O
early	B:C1833334
-	I:C1833334
onset	I:C1833334
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
.	O

Disease	O
evolution	O
in	O
late	O
-	O
onset	O
and	O
early	O
-	I:C1833334
onset	I:C1833334
systemic	B:C0024141
lupus	I:C0024141
erythematosus	I:C0024141
.	O

The	O
objective	B:C0018017
of	O
this	O
study	O
was	O
to	O
compare	O
clinical	O
features	O
,	O
disease	O
activity	O
,	O
and	O
outcome	O
in	O
late	O
-	O
onset	O
versus	O
early	O
-	I:C1833334
onset	I:C1833334
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
(	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
)	O
over	O
5	O
years	O
of	O
follow	O
up	I:C1522577
Method	O
Patients	O
with	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
since	O
1970	O
were	O
followed	O
prospectively	O
according	O
to	O
standard	O
protocol	I:C0008971
and	O
tracked	O
on	O
a	O
computerized	O
database	O
.	O

The	O
objective	O
of	O
this	O
study	B:C2603343
was	O
to	O
compare	O
clinical	O
features	O
,	O
disease	O
activity	O
,	O
and	O
outcome	O
in	O
late	O
-	O
onset	O
versus	O
early	O
-	I:C1833334
onset	I:C1833334
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
(	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
)	O
over	O
5	O
years	O
of	O
follow	O
up	I:C1522577
Method	O
Patients	O
with	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
since	O
1970	O
were	O
followed	O
prospectively	O
according	O
to	O
standard	O
protocol	I:C0008971
and	O
tracked	O
on	O
a	O
computerized	O
database	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
compare	O
clinical	O
features	O
,	O
disease	O
activity	O
,	O
and	O
outcome	B:C0679250
in	O
late	O
-	O
onset	O
versus	O
early	O
-	I:C1833334
onset	I:C1833334
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
(	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
)	O
over	O
5	O
years	O
of	O
follow	O
up	I:C1522577
Method	O
Patients	O
with	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
since	O
1970	O
were	O
followed	O
prospectively	O
according	O
to	O
standard	O
protocol	I:C0008971
and	O
tracked	O
on	O
a	O
computerized	O
database	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
compare	O
clinical	O
features	O
,	O
disease	O
activity	O
,	O
and	O
outcome	O
in	O
late	O
-	O
onset	O
versus	O
early	B:C1833334
-	I:C1833334
onset	I:C1833334
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
(	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
)	O
over	O
5	O
years	O
of	O
follow	O
up	I:C1522577
Method	O
Patients	O
with	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
since	O
1970	O
were	O
followed	O
prospectively	O
according	O
to	O
standard	O
protocol	I:C0008971
and	O
tracked	O
on	O
a	O
computerized	O
database	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
compare	O
clinical	O
features	O
,	O
disease	O
activity	O
,	O
and	O
outcome	O
in	O
late	O
-	O
onset	O
versus	O
early	O
-	I:C1833334
onset	I:C1833334
systemic	B:C0024141
lupus	I:C0024141
erythematosus	I:C0024141
(	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
)	O
over	O
5	O
years	O
of	O
follow	O
up	I:C1522577
Method	O
Patients	O
with	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
since	O
1970	O
were	O
followed	O
prospectively	O
according	O
to	O
standard	O
protocol	I:C0008971
and	O
tracked	O
on	O
a	O
computerized	O
database	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
compare	O
clinical	O
features	O
,	O
disease	O
activity	O
,	O
and	O
outcome	O
in	O
late	O
-	O
onset	O
versus	O
early	O
-	I:C1833334
onset	I:C1833334
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
(	O
systemic	B:C0024141
lupus	I:C0024141
erythematosus	I:C0024141
)	O
over	O
5	O
years	O
of	O
follow	O
up	I:C1522577
Method	O
Patients	O
with	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
since	O
1970	O
were	O
followed	O
prospectively	O
according	O
to	O
standard	O
protocol	I:C0008971
and	O
tracked	O
on	O
a	O
computerized	O
database	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
compare	O
clinical	O
features	O
,	O
disease	O
activity	O
,	O
and	O
outcome	O
in	O
late	O
-	O
onset	O
versus	O
early	O
-	I:C1833334
onset	I:C1833334
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
(	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
)	O
over	O
5	O
years	O
of	O
follow	B:C1522577
up	I:C1522577
Method	O
Patients	O
with	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
since	O
1970	O
were	O
followed	O
prospectively	O
according	O
to	O
standard	O
protocol	I:C0008971
and	O
tracked	O
on	O
a	O
computerized	O
database	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
compare	O
clinical	O
features	O
,	O
disease	O
activity	O
,	O
and	O
outcome	O
in	O
late	O
-	O
onset	O
versus	O
early	O
-	I:C1833334
onset	I:C1833334
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
(	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
)	O
over	O
5	O
years	O
of	O
follow	O
up	I:C1522577
Method	O
Patients	O
with	O
systemic	B:C0024141
lupus	I:C0024141
erythematosus	I:C0024141
since	O
1970	O
were	O
followed	O
prospectively	O
according	O
to	O
standard	O
protocol	I:C0008971
and	O
tracked	O
on	O
a	O
computerized	O
database	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
compare	O
clinical	O
features	O
,	O
disease	O
activity	O
,	O
and	O
outcome	O
in	O
late	O
-	O
onset	O
versus	O
early	O
-	I:C1833334
onset	I:C1833334
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
(	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
)	O
over	O
5	O
years	O
of	O
follow	O
up	I:C1522577
Method	O
Patients	O
with	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
since	O
1970	O
were	O
followed	O
prospectively	O
according	O
to	O
standard	B:C0008971
protocol	I:C0008971
and	O
tracked	O
on	O
a	O
computerized	O
database	O
.	O

Patients	O
entering	O
the	O
cohort	B:C0599755
within	O
one	O
year	O
of	O
diagnosis	O
constitute	O
the	O
inception	O
cohort	O
.	O

Patients	O
entering	O
the	O
cohort	O
within	O
one	O
year	O
of	O
diagnosis	B:C0011900
constitute	O
the	O
inception	O
cohort	O
.	O

Patients	O
with	O
late	O
-	O
onset	O
(	O
age	O
at	O
diagnosis	B:C0011900
≥	O
50	O
)	O
disease	O
were	O
identified	O
and	O
matched	O
1:2	O
based	O
on	O
gender	O
and	O
first	O
clinic	O
visit	I:C0008952
(	O
±5	O
)	O
years	O
with	O
patients	O
with	O
early	O
-	O
onset	O
disease	O
(	O
age	O
at	O
diagnosis	O
18	O
-	O
40	O
years	O
)	O
.	O

Patients	O
with	O
late	O
-	O
onset	O
(	O
age	O
at	O
diagnosis	O
≥	O
50	O
)	O
disease	B:C0012634
were	O
identified	O
and	O
matched	O
1:2	O
based	O
on	O
gender	O
and	O
first	O
clinic	O
visit	I:C0008952
(	O
±5	O
)	O
years	O
with	O
patients	O
with	O
early	O
-	O
onset	O
disease	O
(	O
age	O
at	O
diagnosis	O
18	O
-	O
40	O
years	O
)	O
.	O

Patients	O
with	O
late	O
-	O
onset	O
(	O
age	O
at	O
diagnosis	O
≥	O
50	O
)	O
disease	O
were	O
identified	O
and	O
matched	O
1:2	O
based	O
on	O
gender	O
and	O
first	O
clinic	B:C0008952
visit	I:C0008952
(	O
±5	O
)	O
years	O
with	O
patients	O
with	O
early	O
-	O
onset	O
disease	O
(	O
age	O
at	O
diagnosis	O
18	O
-	O
40	O
years	O
)	O
.	O

Patients	O
with	O
late	O
-	O
onset	O
(	O
age	O
at	O
diagnosis	O
≥	O
50	O
)	O
disease	O
were	O
identified	O
and	O
matched	O
1:2	O
based	O
on	O
gender	O
and	O
first	O
clinic	O
visit	I:C0008952
(	O
±5	O
)	O
years	O
with	O
patients	O
with	O
early	O
-	O
onset	O
disease	O
(	O
age	O
at	O
diagnosis	B:C0011900
18	O
-	O
40	O
years	O
)	O
.	O

A	O
total	O
of	O
86	O
patients	O
with	O
late	O
-	O
onset	O
disease	B:C0012634
(	O
84.9	O
%	O
female	O
,	O
81.4	O
%	O
Caucasian	O
,	O
mean	O
age	O
at	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
diagnosis	O
±	O
SD	O
58.05	O
±	O
7.30	O
)	O
and	O
169	O
patients	O
with	O
early	O
-	O
onset	O
disease	O
(	O
86.4	O
%	O
female	O
,	O
71	O
%	O
Caucasian	O
,	O
mean	O
age	O
at	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
diagnosis	O
±	O
SD	O
27.80	O
±	O
5.90	O
)	O
were	O
identified	O
.	O

A	O
total	O
of	O
86	O
patients	O
with	O
late	O
-	O
onset	O
disease	O
(	O
84.9	O
%	O
female	O
,	O
81.4	O
%	O
Caucasian	B:C0043157
,	O
mean	O
age	O
at	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
diagnosis	O
±	O
SD	O
58.05	O
±	O
7.30	O
)	O
and	O
169	O
patients	O
with	O
early	O
-	O
onset	O
disease	O
(	O
86.4	O
%	O
female	O
,	O
71	O
%	O
Caucasian	O
,	O
mean	O
age	O
at	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
diagnosis	O
±	O
SD	O
27.80	O
±	O
5.90	O
)	O
were	O
identified	O
.	O

A	O
total	O
of	O
86	O
patients	O
with	O
late	O
-	O
onset	O
disease	O
(	O
84.9	O
%	O
female	O
,	O
81.4	O
%	O
Caucasian	O
,	O
mean	O
age	O
at	O
systemic	B:C0024141
lupus	I:C0024141
erythematosus	I:C0024141
diagnosis	O
±	O
SD	O
58.05	O
±	O
7.30	O
)	O
and	O
169	O
patients	O
with	O
early	O
-	O
onset	O
disease	O
(	O
86.4	O
%	O
female	O
,	O
71	O
%	O
Caucasian	O
,	O
mean	O
age	O
at	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
diagnosis	O
±	O
SD	O
27.80	O
±	O
5.90	O
)	O
were	O
identified	O
.	O

A	O
total	O
of	O
86	O
patients	O
with	O
late	O
-	O
onset	O
disease	O
(	O
84.9	O
%	O
female	O
,	O
81.4	O
%	O
Caucasian	O
,	O
mean	O
age	O
at	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
diagnosis	B:C0011900
±	O
SD	O
58.05	O
±	O
7.30	O
)	O
and	O
169	O
patients	O
with	O
early	O
-	O
onset	O
disease	O
(	O
86.4	O
%	O
female	O
,	O
71	O
%	O
Caucasian	O
,	O
mean	O
age	O
at	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
diagnosis	O
±	O
SD	O
27.80	O
±	O
5.90	O
)	O
were	O
identified	O
.	O

A	O
total	O
of	O
86	O
patients	O
with	O
late	O
-	O
onset	O
disease	O
(	O
84.9	O
%	O
female	O
,	O
81.4	O
%	O
Caucasian	O
,	O
mean	O
age	O
at	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
diagnosis	O
±	O
SD	O
58.05	O
±	O
7.30	O
)	O
and	O
169	O
patients	O
with	O
early	O
-	O
onset	O
disease	O
(	O
86.4	O
%	O
female	O
,	O
71	O
%	O
Caucasian	B:C0043157
,	O
mean	O
age	O
at	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
diagnosis	O
±	O
SD	O
27.80	O
±	O
5.90	O
)	O
were	O
identified	O
.	O

A	O
total	O
of	O
86	O
patients	O
with	O
late	O
-	O
onset	O
disease	O
(	O
84.9	O
%	O
female	O
,	O
81.4	O
%	O
Caucasian	O
,	O
mean	O
age	O
at	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
diagnosis	O
±	O
SD	O
58.05	O
±	O
7.30	O
)	O
and	O
169	O
patients	O
with	O
early	O
-	O
onset	O
disease	O
(	O
86.4	O
%	O
female	O
,	O
71	O
%	O
Caucasian	O
,	O
mean	O
age	O
at	O
systemic	B:C0024141
lupus	I:C0024141
erythematosus	I:C0024141
diagnosis	O
±	O
SD	O
27.80	O
±	O
5.90	O
)	O
were	O
identified	O
.	O

A	O
total	O
of	O
86	O
patients	O
with	O
late	O
-	O
onset	O
disease	O
(	O
84.9	O
%	O
female	O
,	O
81.4	O
%	O
Caucasian	O
,	O
mean	O
age	O
at	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
diagnosis	O
±	O
SD	O
58.05	O
±	O
7.30	O
)	O
and	O
169	O
patients	O
with	O
early	O
-	O
onset	O
disease	O
(	O
86.4	O
%	O
female	O
,	O
71	O
%	O
Caucasian	O
,	O
mean	O
age	O
at	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
diagnosis	B:C0011900
±	O
SD	O
27.80	O
±	O
5.90	O
)	O
were	O
identified	O
.	O

At	O
enrollment	O
,	O
late	O
-	O
onset	O
systemic	B:C0024141
lupus	I:C0024141
erythematosus	I:C0024141
patients	O
had	O
a	O
lower	O
total	O
number	O
of	O
American	O
College	I:C4055473
of	I:C4055473
Rheumatology	I:C4055473
(	I:C4055473
ACR	I:C4055473
)	I:C4055473
criteria	I:C4055473
,	O
with	O
less	O
renal	O
and	O
neurologic	O
manifestations	I:C0027854
.	O

At	O
enrollment	O
,	O
late	O
-	O
onset	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
patients	O
had	O
a	O
lower	O
total	O
number	O
of	O
American	B:C4055473
College	I:C4055473
of	I:C4055473
Rheumatology	I:C4055473
(	I:C4055473
ACR	I:C4055473
)	I:C4055473
criteria	I:C4055473
,	O
with	O
less	O
renal	O
and	O
neurologic	O
manifestations	I:C0027854
.	O

At	O
enrollment	O
,	O
late	O
-	O
onset	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
patients	O
had	O
a	O
lower	O
total	O
number	O
of	O
American	O
College	I:C4055473
of	I:C4055473
Rheumatology	I:C4055473
(	I:C4055473
ACR	I:C4055473
)	I:C4055473
criteria	I:C4055473
,	O
with	O
less	O
renal	O
and	O
neurologic	B:C0027854
manifestations	I:C0027854
.	O

Mean	O
SLE	B:C0451528
Disease	I:C0451528
Activity	I:C0451528
Index	I:C0451528
2000	I:C0451528
(	I:C0451528
SLEDAI	I:C0451528
-	I:C0451528
2K	I:C0451528
)	I:C0451528
scores	I:C0451528
were	O
lower	O
in	O
late	O
-	O
onset	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
,	O
especially	O
renal	O
features	I:C1285911
and	O
anti-dsDNA	O
positivity	I:C2747927
.	O

Mean	O
SLE	O
Disease	I:C0451528
Activity	I:C0451528
Index	I:C0451528
2000	I:C0451528
(	I:C0451528
SLEDAI	I:C0451528
-	I:C0451528
2K	I:C0451528
)	I:C0451528
scores	I:C0451528
were	O
lower	O
in	O
late	O
-	O
onset	O
systemic	B:C0024141
lupus	I:C0024141
erythematosus	I:C0024141
,	O
especially	O
renal	O
features	I:C1285911
and	O
anti-dsDNA	O
positivity	I:C2747927
.	O

Mean	O
SLE	O
Disease	I:C0451528
Activity	I:C0451528
Index	I:C0451528
2000	I:C0451528
(	I:C0451528
SLEDAI	I:C0451528
-	I:C0451528
2K	I:C0451528
)	I:C0451528
scores	I:C0451528
were	O
lower	O
in	O
late	O
-	O
onset	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
,	O
especially	O
renal	B:C1285911
features	I:C1285911
and	O
anti-dsDNA	O
positivity	I:C2747927
.	O

Mean	O
SLE	O
Disease	I:C0451528
Activity	I:C0451528
Index	I:C0451528
2000	I:C0451528
(	I:C0451528
SLEDAI	I:C0451528
-	I:C0451528
2K	I:C0451528
)	I:C0451528
scores	I:C0451528
were	O
lower	O
in	O
late	O
-	O
onset	O
systemic	O
lupus	I:C0024141
erythematosus	I:C0024141
,	O
especially	O
renal	O
features	I:C1285911
and	O
anti-dsDNA	B:C2747927
positivity	I:C2747927
.	O

Over	O
5	O
years	O
,	O
mean	O
SLEDAI	B:C0451528
-	I:C0451528
2	I:C0451528
K	I:C0451528
scores	I:C0451528
decreased	O
in	O
both	O
groups	O
,	O
while	O
mean	O
Systemic	O
Lupus	I:C4049882
International	I:C4049882
Collaborating	I:C4049882
Clinics	I:C4049882
/	I:C4049882
ACR	I:C4049882
Damage	I:C4049882
Index	I:C4049882
(	I:C4049882
SDI	I:C4049882
)	I:C4049882
scores	I:C4049882
increased	O
more	O
significantly	O
in	O
the	O
late	O
-	O
onset	O
group	O
;	O
they	O
developed	O
more	O
cardiovascular	O
,	O
renal	O
,	O
and	O
ocular	O
damage	O
,	O
and	O
had	O
higher	O
prevalence	O
of	O
cardiovascular	O
risk	O
factors	O
.	O

Over	O
5	O
years	O
,	O
mean	O
SLEDAI	O
-	I:C0451528
2	I:C0451528
K	I:C0451528
scores	I:C0451528
decreased	O
in	O
both	O
groups	O
,	O
while	O
mean	O
Systemic	B:C4049882
Lupus	I:C4049882
International	I:C4049882
Collaborating	I:C4049882
Clinics	I:C4049882
/	I:C4049882
ACR	I:C4049882
Damage	I:C4049882
Index	I:C4049882
(	I:C4049882
SDI	I:C4049882
)	I:C4049882
scores	I:C4049882
increased	O
more	O
significantly	O
in	O
the	O
late	O
-	O
onset	O
group	O
;	O
they	O
developed	O
more	O
cardiovascular	O
,	O
renal	O
,	O
and	O
ocular	O
damage	O
,	O
and	O
had	O
higher	O
prevalence	O
of	O
cardiovascular	O
risk	O
factors	O
.	O

Over	O
5	O
years	O
,	O
mean	O
SLEDAI	O
-	I:C0451528
2	I:C0451528
K	I:C0451528
scores	I:C0451528
decreased	O
in	O
both	O
groups	O
,	O
while	O
mean	O
Systemic	O
Lupus	I:C4049882
International	I:C4049882
Collaborating	I:C4049882
Clinics	I:C4049882
/	I:C4049882
ACR	I:C4049882
Damage	I:C4049882
Index	I:C4049882
(	I:C4049882
SDI	I:C4049882
)	I:C4049882
scores	I:C4049882
increased	O
more	O
significantly	O
in	O
the	O
late	O
-	O
onset	O
group	O
;	O
they	O
developed	O
more	O
cardiovascular	B:C0560570
,	O
renal	O
,	O
and	O
ocular	O
damage	O
,	O
and	O
had	O
higher	O
prevalence	O
of	O
cardiovascular	O
risk	O
factors	O
.	O

Over	O
5	O
years	O
,	O
mean	O
SLEDAI	O
-	I:C0451528
2	I:C0451528
K	I:C0451528
scores	I:C0451528
decreased	O
in	O
both	O
groups	O
,	O
while	O
mean	O
Systemic	O
Lupus	I:C4049882
International	I:C4049882
Collaborating	I:C4049882
Clinics	I:C4049882
/	I:C4049882
ACR	I:C4049882
Damage	I:C4049882
Index	I:C4049882
(	I:C4049882
SDI	I:C4049882
)	I:C4049882
scores	I:C4049882
increased	O
more	O
significantly	O
in	O
the	O
late	O
-	O
onset	O
group	O
;	O
they	O
developed	O
more	O
cardiovascular	O
,	O
renal	B:C1408258
,	O
and	O
ocular	O
damage	O
,	O
and	O
had	O
higher	O
prevalence	O
of	O
cardiovascular	O
risk	O
factors	O
.	O

Although	O
the	O
late	O
-	O
onset	O
SLE	O
group	O
had	O
a	O
milder	O
presentation	O
and	O
less	B:C0243095
active	I:C0243095
disease	O
,	O
with	O
the	O
evolution	O
of	O
disease	O
,	O
they	O
developed	O
more	O
organ	O
damage	O
likely	O
as	O
a	O
consequence	O
of	O
cardiovascular	O
risk	O
factors	O
and	O
aging	O
.	O

Although	O
the	O
late	O
-	O
onset	O
SLE	O
group	O
had	O
a	O
milder	O
presentation	O
and	O
less	O
active	I:C0243095
disease	B:C0012634
,	O
with	O
the	O
evolution	O
of	O
disease	O
,	O
they	O
developed	O
more	O
organ	O
damage	O
likely	O
as	O
a	O
consequence	O
of	O
cardiovascular	O
risk	O
factors	O
and	O
aging	O
.	O

Although	O
the	O
late	O
-	O
onset	O
SLE	O
group	O
had	O
a	O
milder	O
presentation	O
and	O
less	O
active	I:C0243095
disease	O
,	O
with	O
the	O
evolution	O
of	O
disease	O
,	O
they	O
developed	O
more	O
organ	B:C0178784
damage	O
likely	O
as	O
a	O
consequence	O
of	O
cardiovascular	O
risk	O
factors	O
and	O
aging	O
.	O

Although	O
the	O
late	O
-	O
onset	O
SLE	O
group	O
had	O
a	O
milder	O
presentation	O
and	O
less	O
active	I:C0243095
disease	O
,	O
with	O
the	O
evolution	O
of	O
disease	O
,	O
they	O
developed	O
more	O
organ	O
damage	O
likely	O
as	O
a	O
consequence	O
of	O
cardiovascular	O
risk	O
factors	O
and	O
aging	B:C0001811
.	O

